At the recent ADA Scientific Sessions, Medtronic presented data from its pivotal trial of the MiniMed 670G/Enlite 3 hybrid closed loop system, designed to provide evidence for regulatory approval.
Medtronic MiniMed 670G Trial Results: 44% Reduction in Hypoglycemia
Posted in Glucose & Insulin